Tirzepatide (Mounjaro)

Weight Loss Program

The greatest weight loss benefits were observed when Tirzepatide is used in combination with lifestyle changes.

TIRZEPATIDE 6 WEEK WEIGHT LOSS PROGRAM

(20MG) $600

Each session is $600 and includes a total of 20mg.

The first session of Tirzepatide will last 6 weeks if following the escalation dosing schedule below:

Weeks 1 -4, Inject 2.5mg (25 units) once a week

Weeks 5 and beyond, Inject 5mg (50 units) once a week

TIRZEPATIDE 10 WEEK WEIGHT LOSS PROGRAM

(40MG) $850

Each session is $850 and includes a total of 40mg.

The first session of Tirzepatide will last 10 weeks if following the escalation dosing schedule below:

Weeks 1 -4, Inject 2.5mg (25 units) once a week

Weeks 5 and beyond, Inject 5mg (50 units) once a week

HOW IT WORKS FOR WEIGHT LOSS

WEIGHT LOSS MEDICATION

Many people are inquiring about which drug is more advantageous for weight loss, Mounjaro (Tirzepatide) or Wegovy (Semaglutide). Mounjaro (Tirzepatide) is a new drug that treats diabetes but has not yet been approved for weight reduction (we anticipate this to occur soon).

Semaglutide, is sold under the names Ozempic and Rybelsus for diabetes and Wegovy for weight loss. Tirzepatide, which acts on two appetite hormone receptors, GIP and GLP-1, is used to treat diabetes and weight reduction. It produces an amazing 20% weight loss on average and is the first drug that targets both GLP-1 and GIP, resulting in more effective glycemic control and appetite suppression.

GLP-1 (Glucagon-like peptide 1) and GIP (Glucose-dependent insulinotropic polypeptide) are the two most significant incretins that influence glucose and lipid metabolism, gut motility, and appetite.

Even though Tirzepatide has been approved for type 2 diabetes, studies indicate that it could be the most effective weight loss drug ever produced. Current guidelines for the brand Monjaro is that insurance firms will not cover Tirzepatide unless you have diabetes, the only approved use.

Thankfully, our compounding pharmacy now produces Terzepatide making it available for the off-label use of weight loss.

Long-acting liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon) GLP-1 drugs have been on the market for more than a decade. Until now, Semaglutide has been regarded as the newest and most powerful weight loss medicine, but Tirzepatide appears to be even more effective at weight loss by stimulating two satiety hormone receptors rather than one. Tirzepatide’s side effects are similar to those of GLP-1 drugs, particularly nausea and gastrointestinal problems. The medicine is started at the lowest dose and gradually increased as time passes to minimize most side effects.

READY TO GET STARTED?

Matrix Hormones serves patients nationwide via telemedicine. To access our weight loss products, please submit your medical intake form to become a patient.

Click the link below to submit your health profile. This intake form is required for anyone purchasing our products.

https://matrixhormones.md-hq.com/registration

Once your intake form has been submitted, our physician will review your file to see if you’re a candidate for this product.

WANT TO MAXIMIZE YOUR RESULTS?

Tirzepatide CAN be combined with one of our Lipotropic injectables for superior results:

MIC+B12

L-Carnitine

FREQUENTLY ASKED QUESTIONS

WHO SHOULD NOT TAKE TIRZEPATIDE?

Tirzepatide is considered to be safe and effective when used as indicated. But every medication comes with risk of adverse side effects. The most common side effects of using Tirzepatide may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation. That is why we start everyone on a low dosage and titrate slowly.

You should notify your healthcare practitioner if you get changes in vision, low blood sugar (hypoglycemia), kidney problems, pancreatitis, or any serious allergic reactions. Symptoms of low blood sugar include sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. Tirzepatide shouldn’t be used if you or your family have a history of certain thyroid cancers such as Medullary thyroid cancer or endocrine neoplasia type 2 .Tirzepatide should not be used in people with a history of pancreatitis. Tirzepatide should be used cautiously for people on other blood sugar lowering medications.

HOW DO I ADMINISTER TIRZEPATIDE?

Administer TIRZEPATIDE subcutaneously to the abdomen once a week. It may help to use different injection sites around the navel each week.

WHAT IS THE DOSE OF TIRZEPATIDE?

All patients start on the lowest dose of Tirzepatide at 2.5mgs injected subcutaneously into belly fat every week. All patients increase by following the titration schedule as tolerated (slower if nauseous), up to a total weekly dose of 5mgs each week.

HOW CAN I ACCESS TIRZEPATIDE?

Once you register and enroll in our system, you will be evaluated by our board-certified physician. If approved, the medication and the supplies will be shipped straight to your home or office.